Tuesday, October 18, 2022 from 10:15 AM to 11:45 AM PDT at Franciscan Rooms C&D
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-22-180-L01-P
Activity Type: An Application-Based Activity
The purpose of this session is to provide an overview of the new and emerging trends in the use of mental health medications. Topics will include the treatment of mood disorders, schizophrenia, substance use disorders, and how these conditions as well as the medications used to manage them can impact the physical health of patients. Speakers will present evidence and clinical practice surrounding the use of mental health medications and apply patient care scenarios and intermittent questions for formative assessment during the session.
 | Moderator: Krystal KC Riccio, Pharm.D., BCACP
Associate professor of Pharmacy Practice, Roseman University of Health Sciences
College of Pharmacy;
Clinical Pharmacist, Center for Behavioral Health
Las Vegas, Nevada
View Biography |
Learning Objectives
1. Evaluate current recommendations, including newer approved medications, for the treatment of mood disorders.
2. Construct monitoring plans for the medications utilized in the treatment of mood disorders.
3. Describe screening tools to improve diagnostic precision (e.g., major depressive disorder versus bipolar disorder).
4. Evaluate current recommendations, including newer approved medications and formulations, for the treatment of schizophrenia.
5. Discuss the risks and benefits of using long-acting injectable formulations in the treatment of schizophrenia.
6. Construct drug therapy monitoring plans for the medications utilized in the treatment of schizophrenia.
7. Evaluate current recommendations and therapeutics for the treatment of each anxiety disorder.
8. Discuss the necessity for acute versus chronic treatment of various anxiety disorders.
9. Construct effective monitoring plans for the medications utilized in the treatment of anxiety disorders.